Publications by authors named "Christian Bubert"

Claim this Profile
B
Binding mode and structure-activity relationships around direct inhibitors of the Nrf2-Keap1 complex.
Eric Jnoff, Claudia Albrecht, John J Barker, Oliver Barker, Edward Beaumont, Christian Bubert

ChemMedChem· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and structure-activity relationship studies of derivatives of the dual aromatase-sulfatase inhibitor 4-{[(4-cyanophenyl)(4H-1,2,4-triazol-4-yl)amino]methyl}phenyl sulfamate.
L W Lawrence Woo, Paul M Wood, Christian Bubert, Mark P Thomas, Atul Purohit

ChemMedChem· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hybrid dual aromatase-steroid sulfatase inhibitors with exquisite picomolar inhibitory activity.
L W Lawrence Woo, Christian Bubert, Atul Purohit, Barry V L Potter

ACS Med Chem Lett· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of aromatase inhibitors and dual aromatase steroid sulfatase inhibitors by linking an arylsulfamate motif to 4-(4H-1,2,4-triazol-4-ylamino)benzonitrile: SAR, crystal structures, in vitro and in vivo activities.
Christian Bubert, L W Lawrence Woo, Oliver B Sutcliffe, Mary F Mahon, Surinder K Chander

ChemMedChem· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of C-17 heterocyclic substituents on the anticancer activity of 2-ethylestra-1,3,5(10)-triene-3-O-sulfamates: synthesis, in vitro evaluation and computational modelling.
Fabrice Jourdan, Christian Bubert, Mathew P Leese, Andrew Smith, Eric Ferrandis

Org Biomol Chem· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new therapeutic strategy against hormone-dependent breast cancer: the preclinical development of a dual aromatase and sulfatase inhibitor.
Paul A Foster, Surinder K Chander, Simon P Newman, L W Lawrence Woo, Oliver B Sutcliffe, Christian Bubert

Clin Cancer Res· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
3,17-disubstituted 2-alkylestra-1,3,5(10)-trien-3-ol derivatives: synthesis, in vitro and in vivo anticancer activity.
Christian Bubert, Mathew P Leese, Mary F Mahon, Eric Ferrandis, Sandra Regis-Lydi

J Med Chem· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual aromatase-steroid sulfatase inhibitors.
L W Lawrence Woo, Christian Bubert, Oliver B Sutcliffe, Andrew Smith, Surinder K Chander

J Med Chem· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Focused libraries of 16-substituted estrone derivatives and modified e-ring steroids: inhibitors of 17beta-hydroxysteroid dehydrogenase type 1.
Nigel Vicker, Harshani R Lawrence, Gillian M Allan, Christian Bubert, Andrew Smith

ChemMedChem· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel, potent inhibitors of 17beta-hydroxysteroid dehydrogenase type 1.
Gillian M Allan, Christian Bubert, Nigel Vicker, Andrew Smith, Helena J Tutill

Mol Cell Endocrinol· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modification of estrone at the 6, 16, and 17 positions: novel potent inhibitors of 17beta-hydroxysteroid dehydrogenase type 1.
Gillian M Allan, Harshani R Lawrence, Josephine Cornet, Christian Bubert, Delphine S Fischer

J Med Chem· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
E-ring modified steroids as novel potent inhibitors of 17beta-hydroxysteroid dehydrogenase type 1.
Delphine S Fischer, Gillian M Allan, Christian Bubert, Nigel Vicker, Andrew Smith

J Med Chem· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First dual aromatase-steroid sulfatase inhibitors.
L W Lawrence Woo, Oliver B Sutcliffe, Christian Bubert, Anna Grasso, Surinder K Chander

J Med Chem· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analogues of neuropeptide Y containing beta-aminocyclopropane carboxylic acids are the shortest linear peptides that are selective for the Y1 receptor.
Norman Koglin, Chiara Zorn, Raphael Beumer, Chiara Cabrele, Christian Bubert

Angew Chem Int Ed Engl· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis